BRPI0819707A2 - Ciclopentanos substituídas tendo atividade de prostaglandina - Google Patents

Ciclopentanos substituídas tendo atividade de prostaglandina

Info

Publication number
BRPI0819707A2
BRPI0819707A2 BRPI0819707-5A BRPI0819707A BRPI0819707A2 BR PI0819707 A2 BRPI0819707 A2 BR PI0819707A2 BR PI0819707 A BRPI0819707 A BR PI0819707A BR PI0819707 A2 BRPI0819707 A2 BR PI0819707A2
Authority
BR
Brazil
Prior art keywords
substituted cyclopentanes
prostaglandin activity
prostaglandin
activity
cyclopentanes
Prior art date
Application number
BRPI0819707-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0819707A2 publication Critical patent/BRPI0819707A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
BRPI0819707-5A 2007-11-29 2008-11-24 Ciclopentanos substituídas tendo atividade de prostaglandina BRPI0819707A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99100307P 2007-11-29 2007-11-29
PCT/US2008/084495 WO2009073432A1 (en) 2007-11-29 2008-11-24 Substituted cyclopentanes having prostaglandin activity

Publications (1)

Publication Number Publication Date
BRPI0819707A2 true BRPI0819707A2 (pt) 2015-06-16

Family

ID=40456785

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819707-5A BRPI0819707A2 (pt) 2007-11-29 2008-11-24 Ciclopentanos substituídas tendo atividade de prostaglandina

Country Status (7)

Country Link
US (2) US8158676B2 (enExample)
EP (1) EP2231162A1 (enExample)
JP (2) JP5566902B2 (enExample)
AU (1) AU2008331597B2 (enExample)
BR (1) BRPI0819707A2 (enExample)
CA (1) CA2706879A1 (enExample)
WO (1) WO2009073432A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9315486B2 (en) 2013-10-29 2016-04-19 Allergan, Inc. Therapeutic cyclopentanols, compositions thereof, and methods for use thereof
CN109072186B (zh) 2016-03-04 2023-06-23 莱兰斯坦福初级大学评议会 利用前列腺素e2进行肌肉再生的组合物和方法
WO2018227134A1 (en) 2017-06-09 2018-12-13 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for preventing or treating muscle conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259516A (en) * 1979-04-02 1981-03-31 The Upjohn Company 19-Hydroxy-inter-oxa-13,14-dihydro-PG1 compounds
US20020013304A1 (en) * 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6090847A (en) * 1997-11-21 2000-07-18 Allergan Sales, Inc. EP2 -receptor agonists as neuroprotective agents for the eye
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
BRPI0605926A2 (pt) * 2005-01-14 2009-05-26 Allergan Inc ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7476755B2 (en) * 2006-05-04 2009-01-13 Allergan, Inc. Therapeutic compounds
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
EP2288385A2 (en) * 2008-04-16 2011-03-02 Allergan, Inc. Combination therapy for glaucoma

Also Published As

Publication number Publication date
US20120178798A1 (en) 2012-07-12
WO2009073432A1 (en) 2009-06-11
US20090143461A1 (en) 2009-06-04
EP2231162A1 (en) 2010-09-29
AU2008331597A1 (en) 2009-06-11
JP2011505361A (ja) 2011-02-24
JP5566902B2 (ja) 2014-08-06
CA2706879A1 (en) 2009-06-11
US8158676B2 (en) 2012-04-17
JP2014221776A (ja) 2014-11-27
US8546603B2 (en) 2013-10-01
AU2008331597B2 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
CR10851A (es) Inhibidores de la actividad de la akt
BRPI0810191A2 (pt) Escova de dentes
BRPI0821759A2 (pt) Ativador de catalisador contínuo
BRPI0810702A2 (pt) Catalisador
EP2165942A4 (en) Plug structure
BRPI0815246A2 (pt) Composição de catalisador
BRPI0821766A2 (pt) Catalisador de ativação rápida
BRPI0821479A2 (pt) Catalisador suportado
BRPI0810559A2 (pt) Macadores de doenças
DK2211626T3 (da) Bagværk
CR10675A (es) Analogos de 2-fenoxipirimidinona
FI20086154A0 (fi) Katalyyttirakenne
BRPI0818902A2 (pt) Ciclopentanos substituídos tendo atividade de prostaglandina
EP2221104A4 (en) CLEANING CATALYST
EP2058447A4 (en) SOIL STRUCTURE
JP2006340727A5 (ja) 再生
JP2006340726A5 (ja) 再生
BRPI0910931A2 (pt) ciclopentanos substituídos terapêuticos
BRPI0819707A2 (pt) Ciclopentanos substituídas tendo atividade de prostaglandina
CR10745A (es) Analogos de pirazol
BRPI0907913A2 (pt) Ciclopentanos substituídos tendo atividade de prostaglandina
DE112007003148A5 (de) Belohnungssystem
FI20075912L (fi) Katalysaattori
UA15700S (uk) Печиво
UA16560S (uk) Печиво

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.